NIH will receive $10.4 billion. Their FY 08 budget was $29.6 billion. With the stimulus appropriation NIH would have a total FY2009 budget of at least $39.9 billion. A major consideration is that funds must be distributed over 18 months to meet the goals of the ARRA.
· $7.4 billion to be distributed proportionally among the NIH’s institutes and centers (ICs) and Common Fund (CF) through the Office of the Director (OD) to fund intramural and extramural research. The current plan is to distribute these funds through existing NIH grants.
INSIDER INFO (added 3/3/09):
Program Directors have been asked to select grants within 5% of the last cycle's pay-line for funding. This will not necessarily be the next grant, but the one(s) with the most "immediate benefit".
Supplements will be awarded to current grants. The funding mechanism has not yet been determined, but justification must not be to simply restore award budgets that were previously cut.
· $800 million would remain in the Office of the Director, with priority given for 2-year, short-term special research grants to be awarded competitively. NIH Challenge Grants in Health and Science Research RFP has been released and focuses on helath and science problems where progress can be expected in two-years.
INSIDER INFO (added 3/3/09):
An RFA for R01s with a project period of two-years and $500,000/year direct costs will be released soon. These grants will be reviewed within one-month of submission. Proposals will be eight-pages
· $500 million for intramural construction in the Buildings and Facilities account,
· $1.0 billion for competitively awarded extramural grants through a dormant National Center for Research Resources (NCRR) program that last received $30 million in FY 2005, exclusively for the repair and modernization of existing academic research facilities. **
· $300 million for NCRR would provide competitive awards for shared instrumentation and other capital equipment for research in support of all NIH activities
** Note: All facility improvement requests (regardless of the source of funds) must be coordinated with Jerry Schlatter, WSU Capital Planning & Development (335-5571).
$400 million to be transferred from the Agency for Healthcare Research and Quality (AHRQ) for health care comparative effectiveness research (CER) .
Many types of funding mechanisms will be supported, but, in general, NIH will focus scientific activities in several areas:
- We will choose among recently peer reviewed, highly meritorious R01 and similar mechanisms capable of making significant advances with a two-year grant. R01 are projects proposed directly from scientists across the country. We will also fund new R01 applications that have a reasonable expectation of making progress in a two-year grant.
- We will accelerate the tempo of ongoing science through targeted supplements to current grants. For example, we may competitively expand the scope of current research awards or supplement an existing award with additional support for infrastructure (e.g., equipment) that will be used in the two-year availability of these funds.
- NIH anticipates supporting new types of activities that fit into the structure of the Recovery Act. It will support a reasonable number of awards to jump start the new NIH Challenge Grant program. This program is designed to focus on health and science problems where progress can be expected in two years. The number of awards and amount of funds will be determined, based on the scientific merit and the quality of applications.
- NIH will also use other funding mechanisms, as appropriate.
NIH is soliciting general thoughts about how the ARRA funds should be used to meet the goals of the Act, please email to bergj@mail.nih.gov
According to Raynard Kington, Acting Director of NIH: (thanks to Michael Skinner for this information)
1.3 billion will go to NCRR ($1 billion for competitive extramural facilities; $300 million for shared instrumentation). Another $500 million goes to intramural facilities and $400 million gets transferred to the Agency for Healthcare Research and Quality.
A total of $8.2 billion goes to the NIH Office of the Director, of which $7.4 billion is transferred to the I/Cs with $800 million remaining in OD for trans-NIH initiatives.
Here is the basic outline of how the $8.2 billion will be spent. There will be three major mechanisms with the bulk of the funding going to mechanisms 1 and 2:
1. R01 applications already in the funding queue
Two years of funding will be provided for those applications that can benefit from two years of funding and align with I/C priorities. A few applications may get four years of funding.
2. Administrative Supplements to existing grants
Existing grants with at least one year to run may be given the opportunity or asked to submit supplements that further the goals of the I/Cs. These will be handled at least in part by requests from the I/Cs and likely with some calls for proposals and could involve equipment, extended funds for postdocs who were not able to move to their own position, summer students, related projects, etc. There may be other priority issues that the I/C staff want to see funded.
3. Challenge Grants
A new RFA will be released within a week or two for a new, two-year program of cross-cutting, highly innovative projects, $1 M total per project. These challenge grants will be for research addressing certain areas in science or public health that NIH thinks can advance significantly in 2 years. NIH will create a shortened application process for these peer-reviewed grants but hasn't said which areas will be targeted (as of 2/18/09).
Because the stimulus bill's aim is to improve the nation's economy, Kington said, NIH would also be sensitive to geographic distribution of the grants it gives.
Mechanisms for the $400 M for AHRQ are not yet finalized.